Program Information
Pharmacy-based Point-of-Care Test & Treat Certificate Program
ACPE Universal Activity #0165-9999-21-066-B01-P
Activity Type: Practice-based
Target Audience: Pharmacists in all practice settings
Release Date: September 1, 2021
Expiration Date: September 1, 2024
Contact Hours: 20.0
Learning Objectives
At the completion of this activity, the pharmacist will be able to:
Module 1: Overview of Testing or Screening for and Treatment of Minor, Nonchronic Health Conditions
Length: 2 hours
- Identify opportunities for pharmacists to utilize testing or screening for and the treatment of minor, nonchronic health conditions within the framework of an established written protocol with a supervising physician.
- Identify the Florida requirements for a written protocol with a supervising physician.
- Describe the required elements of a written protocol between a physician and pharmacist for test and treat.
- Summarize the findings from recent collaborative research projects utilizing Point-of-Care test (POCT), protocols or Collaborative Practice Agreements (CPAs) for treatment for influenza, Streptococcus and minor, nonchronic health conditions and minor uncomplicated infections.
Module 2: Assessing Test Performance and Determining How to Use a Test Appropriately
Length: 1 hour
- Summarize the Clinical Laboratory Improvement Amendments (CLIA) as they pertain to pharmacy point-of-care testing (POCT).
- Differentiate between FDA approval and Emergency Use Authorization (EUA)
- Describe the process of obtaining a Clinical Laboratory Improvement Amendments (CLIA) certificate of waiver in Florida and regulatory requirements for pharmacies functioning as a CLIA-waived laboratory.
- List elements of Good Laboratory Practices recommended for CLIA-waived testing sites.
- Assess test performance and determine how to use a test appropriately.
Module 3: Disease States for Point-of-Care Testing or Screening for and Treatment of Minor, Nonchronic Health Conditions or Screening for and Treatment of Minor, Nonchronic Health Conditions – Infectious Diseases
Length: 3.5 hours
- Summarize the pathophysiology, clinical presentation, nonpharmacologic treatment, pharmacologic treatment, patient counseling and special population’s considerations of the following disease states or conditions.
- Influenza
- Streptococcus
- Minor, uncomplicated infections.
- Herpes Simplex Labialis (HSL) Cold Sores/Fever Blisters
- Uncomplicated cystitis
Module 4: Disease States for Point-of-Care Testing or Screening for and Treatment of Minor, Nonchronic Health Conditions or Screening for and Treatment of Minor, Nonchronic Health Conditions – Skin Conditions
Length: 2.5 hours
- Summarize the pathophysiology, clinical presentation, nonpharmacologic treatment, pharmacologic treatment, patient counseling and special population’s considerations of the following disease states or conditions.
Skin Conditions- Xerosis and Atopic Dermatitis
- Scaley Dermatosis
- Contact Dermatitis
- Insect Stings and Bites
- Lice
- Acne
- Minor Burns and Wounds
- Fungal Skin Infections
Module 5: Brief overview of other Point-of-Care Testing (no minor ailments or treatment authority)
Length: 2 hours
- Explain the pathophysiology, clinical presentation, nonpharmacologic treatment, pharmacologic treatment, patient counseling and special population’s considerations of the following disease states:
- Other Respiratory infections (e.g., Respiratory Syncytial Virus, Coronaviruses)
- HIV – PrEP and PEP
- Hepatitis C Virus
- Sexually Transmitted Infections (e.g., syphilis, chlamydia, and gonorrhea)
- Conjunctivitis
- Helicobacter pylori
- Lyme Disease
- Infectious mononucleosis
Module 6: Use of Point-of-Care Tests to Promote Antimicrobial Stewardship (AS)
Length: 0.5 hours
- Define and summarize antimicrobial stewardship.
- Identify ways that pharmacists can practice stewardship and reduce antimicrobial resistance.
- Discuss how point-of care testing (POCT) can reduce unnecessary antibiotic use and contribute to a pharmacy’s stewardship program.
Module 7: Collaboration with State and Local Health Departments
Length: 0.5 hours
- Identify the role and responsibilities of state and local health departments, especially as they relate to disease surveillance and reporting.
- Outline steps to develop partnerships with state and local health departments around point-of-care testing (POCT) and treatment.
- Summarize the benefits and value of partnering with state and local health departments.
Live/Virtual Training Session (8 hours)
Module 1: Overview of Testing or Screening for and Treatment of Minor, Nonchronic Health Conditions
Length: 0.5 hours
- Discuss key points from the self-study modules.
- Utilize testing or screening for and the treatment of minor, nonchronic health conditions within the frameworks of an established written protocol with a supervising physician.
- Describe how to implement testing or screening for and minor treatment of minor nonchronic health conditions services in your practice.
Module 2: Florida Statutes and Regulations
Length: 1 hour
- Describe the statutes and regulations applicable to testing or screening for and treatment of minor, nonchronic health conditions.
- Identify the signage, reporting, documentation and reporting requirements to patients, other health care providers and public health agencies for services provided.
- Discuss the required components in Florida law for protocol development.
- Explain the mandatory continuing education required by Florida law to provide testing or screening for and treatment of minor, nonchronic health conditions.
Module 3: Physical Assessment
Length: 1.5 hours
- Discuss the value and limitations of various physical assessment procedures, including body temperature, pulse, blood pressure, respiratory rate, cervical lymph node inspection, throat examination, and physical inspection.
- Demonstrate the procedures for conducting a systematic physical assessment and identify normal and critical findings.
- Interpret physical assessment data and recognize limitations of the data.
- Document patient assessment results.
Module 4: Specimen, Test Performance and Results
Length: 1.5 hours
- Describe the basic process of specimen collection for point-of-care testing (POCT).
- Identify a patient specimen that would be appropriate for a Clinical Laboratory Improvement Amendments (CLIA)-waived POCT.
- Describe factors that can influence test performance.
- Explain how test performance influences interpretation of test results.
- Demonstrate the technique involved for the specimen collection types discussed.
Module 5: Application of the Florida Requirements for Testing, Screening and Treatment of Minor Nonchronic Health Conditions (case studies and practical applications)
Length: 3.5 hours
- Identify specific categories of patients who the pharmacist is authorized to test or screen for and treat minor, nonchronic health conditions.
- Describe the physician’s instructions for obtaining relevant patient medical history for the purpose of identifying disqualifying health conditions, adverse reactions, and contraindications to the approved course of treatment.
- Create a process and schedule for the physician to review the pharmacist’s actions under the protocol.
- Identify a process and schedule for the pharmacist to notify the physician of the patient’s condition, tests administered, test results, and course of treatment.
- Demonstrate ability to apply for CLIA waiver.
- Develop a written protocol that includes all legally required components for legally authorized disease states and appropriate lab testing required.
- Apply test and treat protocol information to patient-specific cases based on common pharmacy-based patient interactions.
Target Audience
This course provides pharmacists and student pharmacists with the skills necessary to develop a testing and treatment program for minor, nonchronic health conditions, such as influenza, Group A streptococcus, and minor, uncomplicated infections.
Claiming Credit
Continuing pharmacy education (CPE) credit will be awarded for the certificate training course only. This is a Certificate Program and is primarily constructed to instill, expand or enhance practice competencies through the systematic achievement of specified knowledge, skills, attitudes and performance behaviors.
Successful completion of the live/virtual seminar component involves passing the final exam with a grade of 70 percent or higher and demonstrating proficiency in diagnostic testing techniques. Successful completion of the self-study component involves passing the self-study assessment questions with a grade of 70 percent or higher. Credit is only awarded for completion of the entire 20 contact hour program. Credit must be claimed within 14 days of completing the program (no exceptions). Attendance and participation are required before obtaining CPE credit. Partial credit will not be awarded.
CPE Monitor, is a national, collaborative effort by the Accreditation Council for Pharmacy Education (ACPE) and the National Association of Boards of Pharmacy (NABP) to provide an electronic system for pharmacists and pharmacy technicians to track their completed PCE credits. This system allows pharmacists and pharmacy technicians to log into a comprehensive electronic profile to access information about their completed CPE. All ACPE-accredited providers will be required to use this system. CPE Statements of Credit will no longer be mailed.
All continuing education credits provided by the Florida Pharmacy Association (FPA) will be uploaded to the Florida CE Broker and to CPE Monitor. Lecture Panda is a platform that FPA & NASPA utilizes to submit your CPE credits. You can access all certificate program materials – learning modules, PowerPoint slides, additional learning materials, assessments, and evaluations in this platform. As soon as you complete your evaluation and other instructions, it is validated and automatically sent to CPE Monitor for accreditation so there is no wait time to receive credit. After CPE credits are processed by ACPE and NABP, pharmacists are able to log into their NABP e-Profile and view all of their completed ACPE-accredited CPE credit.
In order to process CPE credits, please provide Lecture Panda with your correct NABP e-Profile ID number and your birth month and day (MMDD format). The NABP e-Profile ID number is currently a 6 or 7-digit number, and it is not your license number or NPI number. If you need to verify the number or have not yet registered for one, visit www.MyCPEMonitor.net as soon as possible.
Florida Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. The FPA is also an approved Department of Health provider of pharmacy continuing education. Continuing professional development credits earned will be reported to the State of Florida through CEBroker.com and also to the CPE MonitorTM Program. Pharmacists and Pharmacy technicians must have an NABP profile number.
Additional Information
Agenda
CE Info
Developer Bios
Disclaimers
Host a Training
Upcoming Trainings